Skip to main content
SpringerLink
Log in

Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Amnesia can be induced in rats in the passive avoidance paradigm by administration of scopolamine, a central muscarinic receptor antagonist. Tacrine or galanthamine, inhibitors of acetylcholinesterase, given in conjunction with scopolamine partially reversed the scopolamine-induced deficit in passive avoidance performance. Four so-called cognitive enhancers, all widely used for the treatment of the symptoms associated with mental aging, cerebral insufficiency and senile memory disorder, were investigated in this paradigm. Piracetam, an extract of Ginkgo biloba, dihydroergocristine and a combination of raubasine with dihydroergocristine, all attenuated the amnesia induced by scopolamine. In contrast, nicergoline had no significant effect. Raubasine alone also failed to significantly attenuate scopolamine-induced amnesia, although some doses of raubasine had a non-significant tendency (P<0.10) to reduce the amnesia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arrigo A, Moglia A, Borsotti L (1982) A double-blind, placebo-controlled, cross-over trial with nicergoline in patients with senile dementia. Int J Clin Pharmacol Res 2:33–41

    Google Scholar 

  • Bailly A, Roux C, Bourgeois M (1974) Etude d'Iskédyl dans les troubles cerebro-vasculaires de sujet âgé. Synthése 2:57–59

    Google Scholar 

  • Baraka A, Harik S (1977) Reversal of central anticholinergic syndrome by galanthamine. JAMA 238:2293–2294

    Google Scholar 

  • Bartus RT, Johnson HR (1976) Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine. Pharmacol Biochem Behav 5:39–46

    Google Scholar 

  • Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction: a critical review. Science 217:408–417

    Google Scholar 

  • Briley M (1985) Neuropharmacological profile of the association raubasine-dihydroergocristine. Circ Metab Cerveau 2 [suppl 1]:161–175

    Google Scholar 

  • Briley M, Moret C (1985) Inhibitory effect of dihydroergocristine on 5HT release from rat hypothalamic slices. Br J Pharmacol 83:353P

    Google Scholar 

  • Chopin P, Briley M (1990) The effects of raubasine and dihydroergocristine on an age-related deficit in passive avoidance learning in rats. J Pharm Pharmacol 42:375–376

    Google Scholar 

  • Chouinard G, Annable L, Ross-Chouinard A, Olivier M, Fontaine F (1983) Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment. Psychopharmacology 81:100–106

    Google Scholar 

  • De Souza RJ, Robinson TN, Cross AJ, Green AR (1989) The effects of tetrahydroaminoacridine on endogenous 5-hydroxytryptamine and dopamine release from rat brain slices. Br J Pharmacol 93:352P

    Google Scholar 

  • Drachman DA, Leavitt J (1974) Human memory and the cholinergic system: a relationship to aging? Arch Neurol 30:113–121

    Google Scholar 

  • Drukarch B, Leysen JE, Stoof JC (1988) Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA), an alleged drug for the treatment of Alzheimer's disease. Life Sci 42:1011–1017

    Google Scholar 

  • Dunnett SB (1985) Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbra-fornix on delayed matching in rats. Psychopharmacology 87:357–363

    Google Scholar 

  • D'Urso R, Falaschi P, Jallamo R, Ruggieri S (1982) Effect of dihydroergocristine on prolactin release from isolated and dispersed rat pituitary cells. Acta Therap 8:109–114

    Google Scholar 

  • Flood JF, Cherkin A (1986) Scopolamine effects on memory retention in mice: a model of dementia? Behav Neurol Biol 45:169–184

    Google Scholar 

  • Giurgea CE, Salama M (1977) Nootropic drugs. Prog Neuropsychopharmacol 1:235–247

    Google Scholar 

  • Glick SD, Zimmerberg B (1972) Amnesic effects of scopolamine. Behav Biol 7:245–254

    Google Scholar 

  • Grau M, Montero JL, Balasch J (1987) Effect of piracetam on electrocortigram and local cerebral glucose utilization in the rat. Gen Pharmacol 18:205–211

    Google Scholar 

  • Growdon JH, Corkin S, Huff FJ, Rosen TJ (1986) Piracetam combined with lecithin in the treatment of Alzheimer's disease. Neurobiol Aging 7:269–276

    Google Scholar 

  • Hindmarch I (1986) Activité de l'extrait de Ginkgo biloba sur la mémoire a court terme. Presse Méd 15:1592–1594

    Google Scholar 

  • Hugonot R, Israël L, Hugonot L (1985) Clinical trial of the effects of a combination of raubasine and dihydroergocristine on psycho-behavioural manifestations in elderly subjects: methodology and results. Circ Metab Cerveau 2 [suppl 1]:176–188

    Google Scholar 

  • Hunter AJ, Murray TK, Jones JA, Cross AJ, Green AR (1989) The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro. Br J Pharmacol 98:79–86

    Google Scholar 

  • Izquierdo I (1991) Role of NMDA receptors in memory. TIPS 12:128–129

    Google Scholar 

  • Ketchum JS, Sidell FR, Crowell EB, Aghajanian GK, Hayes AH (1973) Atropine, scopolamine and ditran: comparative pharmacology and antagonists in man. Psychopharmacologia 28:121–145

    Google Scholar 

  • Kito G (1990) Effects of vinpocetine and nicergoline on cerebral blood flow in anaesthetized dogs. Jpn J Pharmacol Ther 18:119–130

    Google Scholar 

  • Lenègre A, Chermat R, Avril I, Stéru L, Porsolt D (1987) Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse. Pharmacol Biochem Behav 29:625–629

    Google Scholar 

  • Levy R (1987) Tetrahydroaminoacridine and Alzheimer's disease. Lancet i:332

    Google Scholar 

  • Markstein R (1983) Dopamine receptor profile of co-dergocrine (Hydergine) and its components. Eur J Pharmacol 86:145–155

    Google Scholar 

  • Nicholson CD (1990) Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia. Psychopharmacology 101:147–159

    Google Scholar 

  • Okuyama S, Aihara H (1988) Action of nootropic drugs on transcallosal responses in rats. Neuropharmacology 27:67–72

    Google Scholar 

  • Osterreieder W (1987) 9-Amino-1,2,3,4-tetrahydroaminoacridine (THA) is a potent blocker of cardiac potassium channels. Br J Pharmacol 92:521–525

    Google Scholar 

  • Pedata F, Moroni F, Pepeu GC (1984) Effect of nootropic agents on brain cholinergic mechanisms. Clin Neuropharmacol 7:772–773

    Google Scholar 

  • Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ 11:1457–1459

    Google Scholar 

  • Piercey MF, Vogelsang GD, Franklin SR, Tang AH (1987) Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces. Brain Res 424:1–9

    Google Scholar 

  • Rapin JR, Le Poncin Lafitte M (1979) Modèle expérimental d'ischémie cérébrale. Action préventive de l'extrait de Ginkgo. Semaine des Hôpitaux de Paris 55:42–43

    Google Scholar 

  • Roquebert J, Gomond P, Demichel P (1981) Activité antinoradrénergique de la raubasine sur l'aorte thoracique et le canal déférent isolé de rat. J Pharmacol (Paris) 12:393–400

    Google Scholar 

  • Roquebert J, Demichel P, Gomond P, Malek A (1983) Activité de la dihydroergocristine sur les alpha-adrénorécepteurs pré et postsynaptiques du canal déférent isolé de rat. J Pharmacol (Paris) 14:151–159

    Google Scholar 

  • Satoh M, Ishihara K, Iwana T, Tagaky H (1986) Aniracetam augments, and midazolam inhibits the long-term potentiation in guinea-pig hippocampal slices. Neurosci Lett 68:216–220

    Google Scholar 

  • Shintomi K, Egou H, Tanaka T, Itakura T, Yoshimoto K, Matsumoto M, Matsuoka Y (1986) Pharmacological study of nicergoline (I): Protective effect against anoxic brain damages in animals. Folia Pharmacol Jpn 87:445–456

    Google Scholar 

  • Stegink AJ (1972) The clinical use of piracetam, a new nootropic drug. Arzneimittelforschung 22:975–979

    Google Scholar 

  • Stevens DR, Cotman CW (1987) Excitatory actions of tetrahydroaminoacridine (THA) on hippocampal pyramidal neurons. Neurosci Lett 79:301–305

    Google Scholar 

  • Summers WK, Majovski LV, March GM, Tachiki K, Kling A (1986) Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 315:1241–1245

    Google Scholar 

  • Tariot PN, Caine ED (1987) Oral tetrahydroaminoacridine in the treatment of senile dementia, Alzheimer's type. N Engl J Med 316:1604–1605

    Google Scholar 

  • Taylor JE (1986) Liaisons des neuromédiateurs à leurs récepteurs dans le cerveau de rats: effet de l'administration chronique de l'extrait de Ginkgo biloba. Presse Méd 15:1491–1493

    Google Scholar 

  • Tea S, Clesis P, Clanet M, Marc-Vergnes JP (1979) Effets cliniques hémodynamiques et métaboliques de l'extrait de Ginkgo biloba en pathologie vasculaire cérébrale. Gaz Méd France 86:4149–4152

    Google Scholar 

  • Thouvenot P, Guerci O, Laurens MH (1984) Alterations in cerebral blood flow and behavioural changes in elderly patients treated with nicergoline. Psychol Med (Paris) 16:1571–1585

    Google Scholar 

  • Vorberg G (1985) Ginkgo biloba extract (GBE): a long-term study of chronic cerebral insufficiency in geriatric patients. Clinical Trials J 22:149–157

    Google Scholar 

  • Wesnes K, Anand R, Simpson P, Christmas L (1990) The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers. J Psychopharmacol 4:219–232

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre de Recherche Pierre Fabre, 17 avenue Jean Moulin, F-81106, Castres, France

    Philippe Chopin & Mike Briley

Authors
  1. Philippe Chopin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mike Briley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chopin, P., Briley, M. Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats. Psychopharmacology 106, 26–30 (1992). https://doi.org/10.1007/BF02253584

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02253584

Key words

Search

Navigation